Flex Pharma (FLKS) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts FLKS Hot Sheet
Join SI Premium – FREE
Flex Pharma (NASDAQ: FLKS) reported Q3 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on Flex Pharma (FLKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
